The global MEK inhibitors market is anticipated to grow at a significant CAGR during the forecast period. The major factor anticipated to propel the MEK inhibitors market includes continuous clinical trials and studies on MEK inhibitors as a new treatment option in the field of oncology. MEK inhibitors have already shown promising results for skin cancer; this has propelled researchers to be actively involved in the R&D of MEK inhibitors for the purpose of expansion of their application to other invasive forms of cancer indications, such as colorectal cancer. For instance, MEK inhibitors are under clinical trial for the treatment of patients experiencing metastatic colorectal cancer, which is under phase 3 study.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/mek-inhibitors-market
Another factor that is anticipated to propel the MEK inhibitors market during the forecast period includes high target analogy and specificity. Moreover, product approvals are also serving as the major driver for the growth of the global MEK inhibitors market. For instance, in January 2019, ONO PHARMACEUTICAL CO., LTD. received manufacturing and marketing approval for MEKTOVI MEK inhibitors in Japan for the treatment of metastatic melanoma with BRAFV600 mutations. The company has also taken substantial steps to commercialize this drug in major economies of North America. In May 2017, ONO PHARMACEUTICAL CO., LTD., and Array BioPharma Inc. signed a license agreement to develop and commercialize MEKTOVI in the US and Canada.
Some key players operating in the market include AstraZeneca Plc, F. Hoffmann-La Roche Ltd., Novartis AG, and Ono Pharmaceutical Co. Ltd. These players are eyeing on strengthening their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on.
Global MEK inhibitors Market – Segmentation
By Type
- MEKINIST
- COTELLIC
- MEKTOVI
A full report of MEK inhibitors Market is available at: https://www.omrglobal.com/industry-reports/mek-inhibitors-market
MEK inhibitors Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Cisco Systems, Inc.
- Purple
- Ruckus Networks
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/